GPER1 and neoplasm: The recent identification of the involvement of a G protein-coupled estrogen receptor GPR30 (IUPHAR designation: GPER) in tumor signaling pathways and studies demonstrating the prognostic value of assessing GPER expression suggest GPER may serve as a potentially important biomarker and therapeutic target in cancer [5]–[9].